Dose-dense AC Followed by Paclitaxel/Trastuzumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of doxorubicin and cyclophosphamide followed by paclitaxel and trastuzumab, used as a neoadjuvant or adjuvant treatment for HER-2/neu-positive breast cancer.

**Synonyms:** - Dose-dense AC Followed by Paclitaxel-Trastuzumab Regimen - Dose-dense AC Followed by Paclitaxel/Trastuzumab - Dose-dense Adriamycin/Cytoxan Followed by Paclitaxel/Trastuzumab - Dose-dense Doxorubicin/Cyclophosphamide Followed by Paclitaxel/Trastuzumab - ddAC-TH (Paclitaxel) - ddAC-TH (Paclitaxel) (trastuzumab-anns) - ddAC-TH (Paclitaxel) (trastuzumab-dkst) - ddAC-TH (Paclitaxel) (trastuzumab-dttb) - ddAC-TH (Paclitaxel) (trastuzumab-herw) - ddAC-TH (Paclitaxel) (trastuzumab-pkrb) - ddAC-TH (Paclitaxel) (trastuzumab-qyyp) - ddAC-TH (Paclitaxel) (trastuzumab-strf) - ddAC-TH (Paclitaxel) (trastuzumab-zerc)